Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase I Extension Trial of Repeated Infusions of ISF35

This study has been completed.
Sponsor:
Information provided by:
Memgen, LLC
ClinicalTrials.gov Identifier:
NCT00783588
First received: October 30, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)